IBD in the time of corona - vigilance for immune-mediated diseases
- PMID: 32555385
- PMCID: PMC7301345
- DOI: 10.1038/s41575-020-0333-5
IBD in the time of corona - vigilance for immune-mediated diseases
Abstract
The gastrointestinal tract represents a target organ for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting a thorough discussion on the consequences, particularly regarding inflammatory bowel diseases. Here, aspects of gastrointestinal involvement with SARS-CoV-2, the role of viruses as modulators of mucosal immunity and as treatment-related safety hazards, and the current clinical evidence will be discussed.
Trial registration: ClinicalTrials.gov NCT04276688 NCT04354259.
Conflict of interest statement
The author declares no competing interests.
References
Publication types
MeSH terms
Associated data
LinkOut - more resources
- Full Text Sources
- Medical
- Miscellaneous
 
        